Abiopharma

🔍 SHORT JAY M PHD (Executive)

Company: BioAtla, Inc. (BCAB)

Report Date: 2025-08-31

Detailed Transactions and Holdings:

• Sold 6,347 shares of Common Stock at $0.4555 per share (Direct)
  Date: 2025-08-31 | Code: F | equity_swap_involved: false | shares_owned_after: 2,243,678.00 | transaction_form_type: 4 | Footnotes: F1
• Holds 0 shares of Common Stock (Direct)
  Date: 2025-08-31 | Code: H | nature_of_ownership: By Spouse | shares_owned_after: 793,547.00
• Holds 0 shares of Common Stock (Direct)
  Date: 2025-08-31 | Code: H | nature_of_ownership: By Carolyn Short 2020 Irrevocable Gift Trust | shares_owned_after: 258,727.00
• Holds 0 shares of Common Stock (Direct)
  Date: 2025-08-31 | Code: H | nature_of_ownership: By Jay Short 2020 Irrevocable Gift Trust | shares_owned_after: 258,727.00
• Holds 0 shares of Common Stock (Direct)
  Date: 2025-08-31 | Code: H | nature_of_ownership: By Capia IP, LLC | shares_owned_after: 302,324.00
• Holds 0 shares of Common Stock (Direct)
  Date: 2025-08-31 | Code: H | nature_of_ownership: By Himalaya Parent LLC | shares_owned_after: 50.00 | Footnotes: F2

Footnotes:

• F1: This transaction is not a sale of shares by the Reporting Person. Instead, this represents shares that have been withheld by the Issuer to satisfy its income tax and withholding and remittance obligations in connection with the vesting and net settlement of previously reported restricted stock units.
• F2: The Reporting Person and his spouse are the managers of Himalaya Parent LLC and collectively make investment decisions on the behalf of the entity. The Reporting Person and his spouse disclaim beneficial ownership of the reported securities except to the extent of his or her pecuniary interest therein.